בדיקת מהירות אינטרנט
אזרחות פורטוגלית
הוצאת דרכון פורטוגלי
אלי אקספרקס, הלבנת שיניים סופר פארם
סלקום פיננסי, אמריקן לייזר טלפון תל אביב, בנק הפועלים און ליין
קניית ויאגרה מקורית
турбофорекс отзывы
turboforex отзывы
baner

Management Team

Mike Judy
CEO

quantumsystem
aliexpress в рублях
olymp trade развод
Mike Judy joined Refocus Group in 2013 as the Chief Executive Officer, bringing with him 30 years of experience in the ophthalmology industry. Prior to joining Refocus, he most recently served as Chief Commercial Officer for AcuFocus, leading the sales and marketing team as they introduced the KAMRA™ corneal inlay.

Mr. Judy’s previous experience also includes his role as the Vice President of Global Surgical Marketing for Bausch and Lomb, where he was responsible for the cataract and refractive businesses. He joined B&L through the acquisition of Eyeonics, manufacturer of the Crystalens®. At Eyeonics, Mr. Judy led the sales and marketing team that captured the number one market share position in the premium IOL market. He has also served on various industry boards throughout his career.

Mr. Judy has a BA from Princeton University.

Zack Thompson
CFO and SVP of Business Development

Zack Thompson joined Refocus in January of 2011 as SVP of Finance and Business Development, and was promoted to CFO and SVP of Business Development in April of 2011. Along with his many academic achievements, he has gained much success as a venture partner for several firms and is able to utilize this experience in his role at Refocus.

Previously, Mr. Thompson was a venture partner at the consulting firm Red River Partners. From 2005 to 2008, he was a Project Manager at Hines, an international real estate investment and development firm, where he developed, acquired, or divested $1.2 billion in assets. Starting in 2000, Mr. Thompson was an associate with Polaris Venture Partners, where he invested more than $75 million in early stage medical and information technology businesses. He also served as Manager of Channel Sales and Operations for a Polaris portfolio company in the medical IT space known as Expresiv Technologies. From 1998 to 2000, Mr. Thompson was an Investment Banking Analyst in the Communications, Media, Entertainment, and Technology group at Goldman Sachs, where he conducted over $65 billion in transaction volume.

Mr. Thompson earned his MBA with majors in finance and real estate from the Wharton School at the University of Pennsylvania, where he graduated in the top 5% of his class as a Palmer Scholar. He also has a BA, with honors, from Princeton University’s Woodrow Wilson School.

Martin A. Kaufman, RAC
Chief Regulatory Officer

Martin Kaufman joined Refocus Group in 2014 as Chief Regulatory Officer, and directs all Regulatory Affairs and Quality Assurance activities. His global experience with regulatory compliance plays a key role in Refocus’ clinical operations.

Previously, Martin served as Vice President of Regulatory Affairs – Cataract Surgical Products, for Alcon, managing US regulatory activities, and providing registration support to international affiliates worldwide. From 2004 to 2009, he was Director of Regulatory Affairs at Edwards Lifesciences, where he was responsible for the compilation of submissions for the US, the European Union, and Canada. Prior to Edwards, Martin directed regulatory activities for Guidant Corporation’s Coronary Stent Division based in Santa Clara, CA. From 1998 to 2002, Martin was Sr. Director – Quality and Regulatory Affairs Operations, for QLT, Inc. in Vancouver, BC, where he was key in getting Visudyne® approved in the US, Canada, the EU, and Japan.

Martin is RAC certified with the Regulatory Affairs Professional Society (RAPS) and is a member of the American Society for Quality (ASQ). He has over 34 years’ experience in Quality Assurance and Regulatory Affairs roles. Martin received a Bachelor of Science degree in Electrical Engineering Technology from California State Polytechnic University in Pomona.

Kevin J. Cady
Vice President of Marketing & Business Development

Kevin Cady joined Refocus Group in 2015 as Vice President of Marketing & Business Development, bringing with him nearly 25 years of experience in the ophthalmic medical device industry. His extensive background in professional sales and marketing and his robust leadership experience play a key part in his position at Refocus.

Before Refocus, Mr. Cady was the Executive Director of Sales & Marketing at Alimera Sciences, where he successfully managed the Central Region sales force that supported the launch of ILUVIEN, an FDA-approved diabetic macula edema drug. From 2012 to 2014, Mr. Cady was the Regional Business Director for WaveTec Vision Systems, where he was responsible for the marketplace expansion of the Optiwave Refractive Analysis (ORA) system to ophthalmic surgeons. In this role, he was able to resurrect a stalled technology and successfully integrate the technology within the practices of an elite group of influential ophthalmologists, resulting in Alcon’s acquisition of the company. Prior to this, Mr. Cady was the Area Vice President of Sales for Bausch Lomb Surgical, after the company acquired Eyeonics. In this position, he directed the sales efforts of the company’s entire Ophthalmic Surgical Portfolio and provided leadership for 4 regions, securing the lead rank in sales and market share growth for all products nationally. Mr. Cady was with Alexander Eye Institute from 1996 to 2002, where he held the position of Director of Business Relations. As an industry leader in Practice Management, he designed and implemented an innovative business plan where he achieved top status as one of the nation’s most advanced vision correction ophthalmic providers.

Mr. Cady has a BS in Economics from Illinois State University.

David Ozinga
Vice President of Manufacturing Operations

David Ozinga joined Refocus Group as Vice President of Manufacturing Operations in 2008, after nearly 20 years of medical device manufacturing and engineering experience. With roots in managing the development and manufacturing of medical devices across various health care companies, he is an accomplished industry leader.

Prior to Refocus, he was Vice President of Operations with Galt Medical, overseeing all aspects of guidewire, vascular introducer, and specialty custom kit production. From 1997 to 2004, Mr. Ozinga was Vice President of Manufacturing Operations for Imagyn Medical Technologies, where he managed the manufacturing of laparoscopic instrumentation and radioactive brachytherapy sources. He was also responsible for all supply chain management activities, developing domestic and international contract manufacturing sources for multiple products. Prior to Imagyn Medical Technologies, Mr. Ozinga worked for 10 years at B. Braun Medical in the development and manufacture of intravenous infusion systems, including the automation of numerous processes for disposable set production.

Mr. Ozinga has the CPM designation from the Institute of Supply Management, and a BS in Mechanical Engineering from Virginia Tech.

Selene A. Burke, OD
Vice President of Clinical Affairs

Dr. Selene Burke joined Refocus Group in 2006 and currently serves as Vice President of Clinical Affairs. She is a glaucoma-certified optometrist with extensive clinical experience in multispecialty practices. Since joining Refocus Group, Dr. Burke has managed the organization, training, and execution of all domestic and international clinical trials. She works alongside optometrists and ophthalmologists from around the world in implementing the VisAbility™ Procedure into their practices.

Dr. Burke began her optometric career at Vision Wellness and Laser Center in Richardson, Texas, where she provided comprehensive pre- and postoperative patient care to refractive and cataract patients while playing a significant role in establishing the practice’s first on-site laser center. During Dr. Burke’s tenure, she was also an authority on specialty contact lenses with special interests in the treatment and management of patients with irregular corneas and ocular disease. In 2004, Dr. Burke joined Vision Quest Eye Care and Surgery Center in Dallas, Texas, where she provided pre- and postoperative care to refractive, cataract, glaucoma, and retinal surgery patients. She also developed and implemented clinical protocols for ophthalmic examination, medical assisting, and insurance coding, while providing direct supervision, instruction, and training to the ophthalmic staff.

Dr. Burke received her OD from Southern College of Optometry in Memphis, Tennessee, has an MS in Zoology from Auburn University, and has a BS in Biology from Rust College.

Ian Makepeace
Europe Director of Operations

Ian Makepeace joined Refocus in 2013 as the European Director of Operations. He brings 30 years of ophthalmology experience to Refocus Group, providing a solid understanding of the industry and the European market.

He previously had an extensive career with Alcon, working in the USA and Europe. During his time at Alcon, Mr. Makepeace served in various sales and marketing roles. He was involved in bringing new products to market across the portfolio of surgical equipment, disposables, and IOLs, including the global market-leading AcrySof® lens. Throughout his career, he has represented the industry at all levels within the medical community. Also, he currently serves as Chief Executive of Optic UK, the UK industry trade association, where he works to represent industry interests across the entire range of health care stakeholders.